Skip to main content
Equibles

SummitTX Capital, L.P.

Position in LRMR — Larimar Therapeutics, Inc.

CIK 2052310 FORT WORTH, TX
Back to LRMR Full portfolio

Position in LRMR

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,074,466
-$634,476 QoQ
Shares Held
352,284
-7.2% QoQ
Ownership
0.339%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#28
of 163 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in LRMR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

SummitTX Capital, L.P. holds $220,272,212 across 62 Biotechnology names. LRMR ranks #44 (0.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RYTM
Rhythm Pharmaceuticals, Inc.
 126,401 $14,034,303
2 RARE
Ultragenyx Pharmaceutical Inc.
 374,270 $12,496,875
3 CYTK
Cytokinetics Inc
 112,893 $9,617,354
4 CLDX
Celldex Therapeutics, Inc.
 254,959 $9,487,024
5 QTTB
Q32 Bio Inc.
 733,774 $9,348,280
6 GMAB
Genmab A/S
 318,408 $8,746,667
7 JAZZ
Jazz Pharmaceuticals plc
 36,276 $8,741,427
8 ABVX
Abivax S.A.
 65,216 $8,690,684

All Filings in LRMR

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,074,466 352,284
2026-03-31 $1,708,942 379,765